Search

Your search keyword '"Arora, Prerna"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Arora, Prerna" Remove constraint Author: "Arora, Prerna" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
199 results on '"Arora, Prerna"'

Search Results

4. Who Is Treating Periprosthetic Femur Fractures? An Analysis of the Periprosthetic Research Consortium

6. Omicron subvariant BA.5 efficiently infects lung cells

20. Psychosocial interventions for use in pediatric primary care: an examination of providers' perspectives

21. The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant

22. SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications

23. SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodies

24. Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy

25. SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination

28. SARS-CoV-2 neutralizing camelid heavy-chain-only antibodies as powerful tools for diagnostic and therapeutic applications

29. Cycloserine did not increase depression incidence or severity at standard dosing for MDR-TB

30. Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India

31. Interferon induction and not replication interference mainly determines anti-influenza virus activity of defective interfering particles

33. B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccination

34. SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccination

36. SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

37. Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity

41. Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India.

42. Experiences with Horizontal and Vertical Integration in Competency-based Physiology Education.

46. Down syndrome with microgranular variant of acute promyelocytic leukemia in a child: a case report

47. Immunoglobulin G kappa biclonal gammopathy associated with multiple myeloma, plasmacytoma and cast nephropathy

50. Filariasis of Stensen’s Duct: An Index Case

Catalog

Books, media, physical & digital resources